InvestorsHub Logo
Followers 24
Posts 5060
Boards Moderated 0
Alias Born 07/18/2006

Re: BAR123 post# 410879

Friday, 04/14/2023 9:26:11 AM

Friday, April 14, 2023 9:26:11 AM

Post# of 469500
A biopharma partner would not be concerned with having an independent chairman of the board. Partners deal with operating management.

This is about governance and finally dealing with the fact that Missling is now more of a liability than an asset. The guy has had free rein to do as he pleases, to the detriment of shareholders. If Anavex is to have a chance at real success, Missling must be replaced.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News